ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells.
Journal Information
Full Title: Acta Pharm Sin B
Abbreviation: Acta Pharm Sin B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest The authors declare no conflicts of interest."
"We acknowledge the assistance of Chinese Academy of Medical Sciences & Peking Union Medical College and the Institute of Materia Medica. This study was supported by 10.13039/501100012166National Key R&D Program of China (No. 2019YFE0111800), 10.13039/501100001809National Natural Science Foundation of China (Nos. T2192972, 81872923, and 81903904), and the CAMS Innovation Fund (2022-I2M-1-014, China)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025